Sanger sequencing

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Genomics, Computational biology, Growth, Prevalence, Consumables, Intelligence, DSM-IV codes, Workflow, NGS, DNA, Cancer, Medicine, Nucleotide, Agilent Technologies, Investment, QIAGEN, Safety, Sanger sequencing, Disorder, Table, Vaccine

DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.

Key Points: 
  • DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.
  • However, the DNA sequencing market faces hurdles, including technical constraints, high costs, and the complexity of data interpretation, which impede broader adoption.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the DNA Sequencing Market.
  • "Dive into the DNA Sequencing Market Landscape: Explore 196 Pages of Insights, 562 Tables, and 24 Figures"

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Genomics, Computational biology, Growth, Prevalence, Consumables, Intelligence, DSM-IV codes, Workflow, NGS, DNA, Cancer, Medicine, Nucleotide, Agilent Technologies, Investment, QIAGEN, Safety, Sanger sequencing, Disorder, Table, Vaccine

DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.

Key Points: 
  • DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.
  • However, the DNA sequencing market faces hurdles, including technical constraints, high costs, and the complexity of data interpretation, which impede broader adoption.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the DNA Sequencing Market.
  • "Dive into the DNA Sequencing Market Landscape: Explore 196 Pages of Insights, 562 Tables, and 24 Figures"

Global Transplant Diagnostics (HLA, Blood Profile, Pathogen Detection) Market Research Report 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 29, 2023
Health, Medical Devices, Hospitals, Surgery, Health Technology, Managed Care, Biotechnology, Liver, NGS, Sanger sequencing, Bone marrow, Heart, Hypertension, HLA, Diabetes, Hospital, Region, Thermo Fisher Scientific, PCR, USD, Chronic kidney disease, Obesity, Transplant, Growth, Patient, Instrument

The "Global Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User & Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User & Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The transplant diagnostic market is projected to reach USD 6.8 billion by 2028 from USD 4.4 billion in 2022, at a CAGR of 7.4%.
  • This report studies the transplant diagnostic market based on product & service, technology, application, end user, and region.
  • It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders.

Dotmatics Acquires SoftGenetics Expanding Into Clinical and Forensic Genetic Analysis

Retrieved on: 
Monday, June 12, 2023
NextGen Healthcare, NGS, DNA, Growth, Acquisition, Research, Health, GeneMark, Sanger sequencing, Management, Dotmatics

BOSTON, June 12, 2023 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it has acquired SoftGenetics, a bioinformatics software company that offers a range of advanced genetic analysis products for research, forensics, and healthcare applications.

Key Points: 
  • "With more than 22 years of experience, SoftGenetics has deep expertise in a wide range of sequencing technologies, taking complex genetic data and making it actionable for clinicians and forensic investigators," said Thomas Swalla, CEO of Dotmatics.
  • "Adding these powerful genetic analysis tools strengthens the Dotmatics portfolio with more comprehensive and diverse solutions to help us advance scientific research, discovery, and clinical outcomes for our customers."
  • SoftGenetics' products, known for their high sensitivity, accuracy, and low false positive rates, play a crucial role in research, healthcare, and forensics.
  • "This move presents an exciting opportunity for our SoftGenetics team to further expand the reach and impact of our genetic analysis products," said Dr. Changsheng Liu, co-founder and vice president of R&D at SoftGenetics.

Global Agrigenomics Market Research Report 2023: Market to Reach $6.1 Billion by 2030 from $3.2 Billion in 2022 - Next-Generation Sequencing Presents Promising Opportunities in Plant Breeding Space

Retrieved on: 
Friday, February 3, 2023
Investment, Growth, Food, COVID, Sanger sequencing, Risk, Climate change, Pressure, Video game, Tourism

DUBLIN, Feb. 3, 2023 /PRNewswire/ -- The "Agrigenomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 3, 2023 /PRNewswire/ -- The "Agrigenomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Agrigenomics estimated at US$3.2 Billion in the year 2022, is projected to reach a revised size of US$6.1 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2022-2030.
  • Illumina Hi Seq Family, one of the segments analyzed in the report, is projected to record a 9% CAGR and reach US$3.1 Billion by the end of the analysis period.
  • Taking into account the ongoing post pandemic recovery, growth in the Sanger Sequencing segment is readjusted to a revised 8.5% CAGR for the next 8-year period.

Sequencing Reagents Market To Reach USD 15.9 Billion By 2028 With A CAGR Of 16.4%| Valuates Reports

Retrieved on: 
Friday, February 3, 2023
DNA, Mutation, Pulsus Group, DNA sequencing, Pharmacology, NGS, Third-generation sequencing, Projection, Medication, Oncology, Patient, RNA, Research, USD, Growth, Neoplasm, Sanger sequencing, Cancer, Fine chemical, Medical imaging

The global Sequencing Reagents Market size is estimated to be worth USD 5.5 billion in 2021 and is forecast to a readjusted size of USD 15.9 billion by 2028 with a CAGR of 16.4% during the review period.

Key Points: 
  • The global Sequencing Reagents Market size is estimated to be worth USD 5.5 billion in 2021 and is forecast to a readjusted size of USD 15.9 billion by 2028 with a CAGR of 16.4% during the review period.
  • The two main variables that will affect the growth of the sequencing reagents market are advances in sequencing techniques and falling costs for genetic sequencing.
  • Additionally, the Sequencing Reagents market is expanding at an accelerated rate due to the spike in the usage of sequencing techniques and different developments.
  • This factor is expected to drive the growth of the Sequencing Reagents market.

Plant Phenotyping Market worth $437 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 12, 2023
Photon, Water, Sanger sequencing, Keygen, Soil, Quality assurance, Developing country, CropDesign, Vienna, Government, Rothamsted Research, SE, Crop, BASF, Convention (norm), WPS, Objective, Organization, Czech Republic, Growth, Safety testing of explosives, Software, Plant, ABI Solid Sequencing, Food, Satellite navigation device, Agriculture, Livestock, Biosolids, Manure, Region, Compost

The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.

Key Points: 
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • These are standalone or additional accessories that can be installed in plant phenotyping equipment systems.
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • High emphasis on funding for plant phenotyping experiments from the government and other organizations in Europe and North America has played a vital role in the growth of the plant phenotyping market in these regions.

Plant Phenotyping Market worth $437 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, January 12, 2023
Photon, Water, Sanger sequencing, Keygen, Soil, Quality assurance, Developing country, CropDesign, Vienna, Government, Rothamsted Research, SE, Crop, BASF, Convention (norm), WPS, Objective, Organization, Czech Republic, Growth, Safety testing of explosives, Software, Plant, ABI Solid Sequencing, Food, Satellite navigation device, Agriculture, Livestock, Biosolids, Manure, Region, Compost

The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.

Key Points: 
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • These are standalone or additional accessories that can be installed in plant phenotyping equipment systems.
  • The image analysis segment is expected to account for the largest share of the plant phenotyping market in 2022.
  • High emphasis on funding for plant phenotyping experiments from the government and other organizations in Europe and North America has played a vital role in the growth of the plant phenotyping market in these regions.

Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference

Retrieved on: 
Monday, November 7, 2022
Memorial Sloan Kettering Cancer Center, Growth, Medical laboratory, Association, University, GLOBE, Government, University of Pennsylvania, Residency, Pathology, Securities Exchange Act of 1934, Mutation, COVID-19, Health, CEO, Securities Act of 1933, Physician, Annual report, U.S. Securities and Exchange Commission, AMP, Coronavirus, Approximation error, NASDAQ, MPN, Sanger sequencing, Technology, Center, Gene, Faculty, Laboratory, Patient, Department, Pharmaceutical industry, Medical device, Audit, HAVEN

The goal of the study was to assess the accuracy of the HemeScreen technology by conducting blinded, side-by-side evaluation of patient samples with known results using two technologies.

Key Points: 
  • The goal of the study was to assess the accuracy of the HemeScreen technology by conducting blinded, side-by-side evaluation of patient samples with known results using two technologies.
  • As stated in the poster conclusions section, results demonstrated exquisite accuracy, sensitivity and specificity of the HemeScreen MPN assay in detecting genetic variants observed in MPN.
  • The AMP annual conference is globally recognized as the largest event focused on molecular diagnostics.
  • The support of such an academically and clinically recognized association through the acceptance of its poster submission strengthens the value proposition of HemeScreen to the market.

Global Whole Exome Sequencing Market Report 2022: Personalized Medicine to Fuel the Demand for WES Technology - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 22, 2022
Health, Genetics, Observation, Agriculture, Biotechnology, Development, Medication, Hospital, Co-production (public services), Risk, Kits, Research, Sanger sequencing, Academy, Geography, Growth, Product, Ansoff Matrix, Industry, Market development, USD, Investment, Drug discovery, Others, Ion semiconductor sequencing, SWOT, SBS, Personalized medicine, CAGR, Fine chemical, Medical device, Retail, Risk management, Technology, System

The Global Whole Exome Sequencing [WES] Market is segmented based on Products and Services, Technology, Applications, End-user, and Geography.

Key Points: 
  • The Global Whole Exome Sequencing [WES] Market is segmented based on Products and Services, Technology, Applications, End-user, and Geography.
  • By Technology, the market is classified into Sequencing By Synthesis (SBS), ION Semiconductor Sequencing, and Other Technologies.
  • The report presents a detailed Ansoff matrix analysis for the Global Whole Exome Sequencing [WES] Market.
  • The report offers a comprehensive evaluation of the Global Whole Exome Sequencing [WES] Market.